Rudy Potenzone, Per Artur Peterson, Robert Kolodner | GenomeWeb
Rudy Potenzone has joined Microsoft as worldwide industry technology strategist for pharmaceuticals. Potenzone was most recently vice president for enterprise solutions at CambridgeSoft. Prior to that, he served as vice president of product management at Ingenuity, president of Lion Biosciences US, senior vice president of research and development at MDL, and director of new product development and research for the American Chemical Society.


Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.